TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 09/15/20

Phase 1 Dosing of Voriconazole Inhalation Powder up to 80 mg/dose in healthy subjects for direct-to-lung delivery of voriconazole for Invasive Pulmonary Aspergillosis (IPA) Phase 2 studies to commence, assessing the efficacy of the dry powder formulation for the treatment of IPA ...

Panel discussion scheduled for Thursday, September 17, 2020 at 11:00 AM EDT TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology ...

Corporate presentation and live webcast scheduled for Monday, September 14, 2020 at 4:00 PM EDT TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film...

Gainers:  VBI Vaccines (NASDAQ: VBIV ) +35% . More news on: VBI Vaccines Inc., Rekor Systems, Inc., BMC Stock Holdings, Inc., Stocks on the move, , Read more ...

Lowered Risk Leads to Long-term Gains TFF Pharmaceuticals ( TFFP ) is a small biotech company that focuses on a novel small molecule/biosimilar aerosolization technique. I find this company to be a necessary asset in a biotech portfolio as it provides an ingenious manufacturing procedure tha...

Gainers:  Midatech Pharma (NASDAQ: MTP ) +59% . More news on: Midatech Pharma plc, Mesoblast Limited, Sky Solar Holdings, Ltd., Stocks on the move, , Read more ...

Taiwan Liposome (NASDAQ: TLC )   +103%  on planned trial of inhaled malaria drug for COVID-19. More news on: Taiwan Liposome Company, Ltd., Mesoblast Limited, Midatech Pharma plc, Stocks on the move, , Read more ...

TFF Pharmaceuticals, Inc. (TFFP) Q2 2020 Earnings Conference Call August 13, 2020 04:30 PM ET Company Participants Paul Sagan - Investor Relations Glenn Mattes - President and Chief Executive Officer Kirk Coleman - Chief Financial Officer Chris Cano - Vice President-Business De...

TFF Pharmaceuticals (NASDAQ: TFFP ) : Q2 GAAP EPS of -$0.20 beats by $0.01 . More news on: TFF Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Thinly traded micro cap TFF Pharmaceuticals (NASDAQ: TFFP ) rallies  24%  after hours in reaction to its agreement with privately held UNION therapeutics A/S potentially granting the latter an exclusive global license to its Thin Film Freezing (TFF) technology used in combinati...